Efficacy and safety of avatrombopag in the treatment of thrombocytopenia after umbilical cord blood transplantation
Abstract. Background:. Delayed platelet engraftment is a common complication after umbilical cord blood transplantation (UCBT), and there is no standard therapy. Avatrombopag (AVA) is a second-generation thrombopoietin (TPO) receptor agonist (TPO-RA) that has shown efficacy in immune thrombocytopen...
Saved in:
| Main Authors: | Aijie Huang, Guangyu Sun, Baolin Tang, Yongsheng Han, Xiang Wan, Wen Yao, Kaidi Song, Yaxin Cheng, Weiwei Wu, Meijuan Tu, Yue Wu, Tianzhong Pan, Xiaoyu Zhu, Sihan Zhou, Xiuyuan Hao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-05-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003216 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK
by: Nichola Cooper, et al.
Published: (2025-03-01) -
Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation
by: Na Li, et al.
Published: (2022-01-01) -
Efficacy and safety of avatrombopag in the treatment of chemotherapy-induced thrombocytopenia in children with acute lymphoblastic leukemia: a single-center retrospective study
by: Huiyan Yang, et al.
Published: (2024-12-01) -
Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: a phase I trial
by: Guangyu Sun, et al.
Published: (2025-07-01) -
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments
by: Andrea Aiello, et al.
Published: (2023-12-01)